Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03778957
Brief Title: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-1)

First Submitted : November 28, 2018
First Submitted that Met QC Criteria : December 17, 2018
First Posted : December 19, 2018

Last Update Submitted that Met QC Criteria : September 15, 2021
Last Update Posted : September 16, 2021